Globus Medical, Inc.
GMEDNYSEHealthcare● Active
$79.30
$-0.70(-0.88%)
Market Cap$10.7B
P/E Ratio—
52W High$101.4
52W Low$51.79
Globus Medical, Inc. (GMED) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GMED · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $0.96B |
| Cost of Revenue | $0.96B | $1.04B | $0.55B | $0.26B | $0.24B |
| Gross Profit | $1.98B | $1.48B | $1.02B | $0.76B | $0.72B |
| Gross Margin %(computed) | 67.41% | 58.90% | 65.05% | 74.22% | 75.03% |
| Operating Expenses | |||||
| R&D Expenses | $0.18B | $0.16B | $0.12B | $0.07B | $0.10B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.50B | $1.32B | $0.89B | $0.53B | $0.55B |
| Operating Income | $0.48B | $0.17B | $0.13B | $0.23B | $0.17B |
| Operating Margin %(computed) | 16.33% | 6.59% | 8.49% | 22.29% | 17.95% |
| Interest Income | $0.01B | $0.00B | $0.02B | $0.01B | $0.01B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.61B | $0.12B | $0.17B | $0.24B | $0.18B |
| Income Tax Expense | $0.07B | $0.02B | $0.04B | $0.05B | $0.03B |
| Net Income | $0.54B | $0.10B | $0.12B | $0.19B | $0.15B |
| Net Margin %(computed) | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 |
| Wtd Avg Shares | 0.14B | 0.14B | 0.11B | 0.10B | 0.10B |
| EBITDA | $0.73B | $0.47B | $0.35B | $0.30B | $0.26B |
| EBITDA Margin %(computed) | 24.84% | 18.80% | 22.10% | 29.77% | 27.63% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Globus Medical, Inc. data
About Globus Medical, Inc. (GMED) Income Statement
Globus Medical, Inc. (GMED) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GMED reported revenue of $2.94B, gross profit of $1.98B (gross margin 67.41%), and net income of $0.54B — a net profit margin of 18.30%.
Frequently asked questions
GMED · 4 questionsGlobus Medical, Inc. (GMED) reported revenue of $2.94B for 2025, up 16.7% year-over-year.
GMED revenueGMED salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08